CSL’s Growth Slows, Profits Surge: What Investors Need to Know
For decades, CSL Limited (ASX: CSL) has been regarded as one of Australia’s most dependable healthcare giants, the kind of stock you could tuck away and forget. Yet in recent years, even this blue-chip defensive stock has shown it is not immune to market turbulence.…
Blue Chip Stocks
CBA’s $15 Billion Wake-Up Call
On the ASX, $15 billion can disappear in a single day, and that is exactly what happened to Commonwealth Bank (ASX: CBA) this week after releasing its 2025 results.
It was not a profit warning, nor a shock loss. In fact, the numbers were strong. But in markets, strength can…
Should you invest in Mastercard or Visa? It is a difficult question for investors to answer. These payment giants hold a virtual monopoly over the global payments system - American Express is a decent sized player, but is still no match for Mastercard (NYSE:MA) and Visa (NYSE:V).
The companies, headquartered in Purchase (in New York State,…
What does it say about a company when one of the world’s biggest private equity firms offers a 30 percent premium to take it off the public market?
That’s the question investors are asking after TPG announced a $651 million all-cash deal to acquire Infomedia Ltd (ASX:IFM), a quiet achiever in the automotive software space. If…
Is this the moment onsemi loses its spark or sets up its biggest comeback yet?
On August 5th, onsemi’s stock (NASDAQ:ON) nosedived 16% in a single day, capping off a brutal year that has already seen the company shed over 22% of its value. It was the worst-performing stock in the S&P 500 that Monday,…
ResMed (ASX:RMD) is one of the few ASX healthcare stocks that has successfully made it in the USA. And while Trump's tariffs have caused headaches for many healthcare stocks, ResMed might even be a beneficiary of them. Yes, there was a temporary dip in the share price, but shares are up more than 20% in…
Everyone is looking for ASX stocks that will last forever - in other words, stocks that won't go bust and will be around for at least long as they are alive.
Phillip Fisher once said,' If the job has been correctly done when a common stock is purchased, the time to sell it is-almost never'. Of…
Five years ago, IperionX (ASX:IPX) was just another small cap treading water with a market cap of $2.7m. Even in April 2023, it was only a tenth of what is now at under $200m, but it has created spectacular wealth for long-term investors. And it didn't happen by accident or coincidence. Luck may have been…
If you want to benefit from the growth of Nvidia but don't have the confidence that you'll be able to reap the returns investors who got in earlier have made, you could invest in Nvidia suppliers.
You see, the world's largest GPU supplier doesn't do it all 'in house', it relies on a number of suppliers.…
Ansell (ASX:ANN) makes latex PPE (Personal Protective Equipment), particularly gloves. Latex gloves are no bottles of Dom Perignon, but they are often essential and you might think they are 'recession-proof', and so this company should only be going in one direction...up. In reality, its more complicated than that, although the company is in better shape…
